Compare Marathon Digital Holdings Inc (MARA) vs Merck & Co., Inc. (MRK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marathon Digital Holdings Inc vs Merck & Co., Inc. — how do they compare? Marathon Digital Holdings Inc trades at $12.02 (market cap $4.45B), while Merck & Co., Inc. trades at $124.78 (market cap $307.25B). The key difference: Merck & Co., Inc. is far larger — about 69× Marathon Digital Holdings Inc's market cap, and Merck & Co., Inc. pays a 2.73% dividend while Marathon Digital Holdings Inc pays none. Which is the better fit depends on your goals.
| MARA | MRK | |
|---|---|---|
Market Cap | $4.45B | $307.25B |
Sector | Technology | Health |
52-Week High | $22.84 | $129.52 |
52-Week Low | $6.73 | $77.60 |
Enterprise Value | $6.40B | $350.66B |
Dividend Yield | — | 2.73% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Marathon Digital Holdings (MARA) trades at $11.67, up 9.17% today, amid a strategic pivot from Bitcoin mining to AI infrastructure. Despite recent earnings misses and negative profitability metrics, the stock shows technical support near $10-11 levels. The company's acquisition of a 1,200-acre Texas site with 2 GW power capacity represents a significant expansion opportunity, though cash flow remains negative from operations.
MARA presents a high-risk opportunity with Wall Street analysts maintaining a 50% buy rating and $16.90 consensus target. The AI pivot could drive long-term growth, but investors face substantial execution risks amid persistent losses and negative cash flow. Near-term performance depends on successful business transformation and improved profitability.
Merck (MRK) trades at $127.5, down slightly (-0.14%) on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $137.30. The company reported strong earnings beats in recent quarters, with Q1 2026 loss narrower than expected, and maintains robust profitability with a net income margin of 13.59%. Recent news highlights Merck's acquisition of Terns Pharmaceuticals to bolster its oncology pipeline, reflecting strategic growth initiatives.
The outlook for MRK is positive, supported by earnings momentum, strategic acquisitions, and strong analyst buy ratings (67.57%). Key risks include rising debt levels, with debt-to-asset ratio increasing to 36.06% in 2025, and competitive pressures in the pharmaceutical sector. The stock offers a dividend yield with a recent $0.85 per share payment, appealing for income-focused investors amid steady revenue growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Marathon Digital Holdings Inc
Marathon Digital Holdings, Inc. is one of the largest publicly traded Bitcoin mining companies in North America. The company focuses on building and operating large-scale, cost-efficient Bitcoin mining facilities. Marathon's strategy centers on increasing its mining hash rate and using sustainable energy sources to expand its Bitcoin production. The company's performance is closely tied to the price of Bitcoin and the overall health of the digital asset mining industry.
Read more on MARA →About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →
